Sale!

Immunohistochemistry BCL2 Test

Original price was: $112.Current price is: $76.

-32%

The Immunohistochemistry BCL2 Test is a specialized diagnostic procedure that detects the presence and expression levels of the BCL2 protein in tissue samples. This critical biomarker test helps identify abnormal cell survival patterns characteristic of various cancers, particularly lymphomas. By analyzing BCL2 expression, healthcare providers can determine cancer aggressiveness, predict treatment response, and develop personalized therapeutic strategies. The test is essential for patients with suspected or confirmed lymphoma, providing valuable insights for accurate diagnosis and prognosis assessment. Available for only $76 USD, this advanced immunohistochemistry analysis offers crucial information for cancer management and treatment planning.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunohistochemistry BCL2 Test: Advanced Cancer Biomarker Analysis

Understanding the Immunohistochemistry BCL2 Test

The Immunohistochemistry BCL2 Test represents a cutting-edge diagnostic approach in modern oncology, specifically designed to detect and quantify the BCL2 protein expression in tissue specimens. This sophisticated laboratory technique utilizes specialized antibodies that bind specifically to the BCL2 protein, allowing pathologists to visualize its presence and distribution within cells. The BCL2 protein plays a crucial role in regulating programmed cell death (apoptosis), and its abnormal expression is strongly associated with various cancer types, particularly lymphoid malignancies.

What Does the BCL2 Test Measure?

This advanced diagnostic test specifically detects:

  • BCL2 protein expression levels in tissue samples
  • Abnormal cell survival patterns characteristic of cancer
  • Specific biomarker patterns indicative of lymphoma subtypes
  • Cellular localization and intensity of BCL2 staining
  • Potential treatment resistance markers

Clinical Importance and Applications

The Immunohistochemistry BCL2 Test serves as a cornerstone in cancer diagnosis and management, providing critical information that directly impacts treatment decisions and patient outcomes. By identifying abnormal BCL2 expression patterns, healthcare providers can distinguish between reactive lymphoid processes and malignant lymphomas, determine cancer aggressiveness, and predict response to specific therapeutic agents.

Who Should Consider This Test?

This test is particularly recommended for individuals experiencing:

  • Unexplained lymph node enlargement or swelling
  • Suspected lymphoma based on clinical presentation
  • Abnormal blood cell counts or bone marrow findings
  • Previous inconclusive biopsy results requiring further characterization
  • Monitoring treatment response in known lymphoma cases
  • Evaluation of recurrent or persistent symptoms suggestive of lymphoid malignancies

Key Benefits of BCL2 Testing

Choosing the Immunohistochemistry BCL2 Test provides numerous advantages for comprehensive cancer care:

  • Accurate Diagnosis: Helps distinguish between benign and malignant lymphoid conditions
  • Prognostic Information: Provides insights into disease aggressiveness and potential outcomes
  • Treatment Guidance: Informs selection of appropriate therapeutic strategies
  • Personalized Medicine: Enables tailored treatment approaches based on biomarker expression
  • Monitoring Capability: Allows assessment of treatment response and disease progression

Understanding Your Test Results

Your BCL2 test results will be interpreted by experienced pathologists and oncologists, providing clear guidance on:

  • Positive BCL2 Expression: Indicates abnormal cell survival mechanisms, often associated with lymphoma
  • Negative BCL2 Expression: Suggests normal apoptosis regulation in the tested tissue
  • Staining Intensity: The strength of BCL2 expression can indicate disease severity
  • Pattern Analysis: Specific staining patterns help classify lymphoma subtypes

Your healthcare provider will discuss the clinical significance of your results and develop an appropriate management plan based on the findings.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $76
Regular Price $112

Turnaround Time and Sample Requirements

Our laboratory maintains efficient processing times to ensure timely results:

  • Sample Submission: Daily by 6 PM
  • Standard Report: 5 days for routine tissue biopsy
  • Complex Cases: 7 days for large or complex tissue specimens

Sample Collection Instructions

For accurate testing, please provide:

  • Tumor tissue preserved in 10% formal-saline solution
  • Formalin-fixed paraffin-embedded tissue blocks
  • Ship samples at room temperature with proper packaging
  • Include complete clinical documentation including histopathology report
  • Provide biopsy site information and detailed clinical history

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Take Action for Your Health

Don’t wait to get the critical diagnostic information you need. The Immunohistochemistry BCL2 Test provides essential insights for cancer diagnosis and management. Our team of experienced oncologists and pathologists is ready to assist you with comprehensive testing and personalized care.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our medical specialists. We’re here to answer your questions, provide guidance, and help you take the next step toward better health outcomes.

Early and accurate diagnosis through advanced biomarker testing like the BCL2 test can significantly impact treatment success and long-term prognosis. Trust our expertise in cancer diagnostics to provide the clarity and direction you need for your healthcare journey.